This article reviews the emerging trend of microdosing GLP-1 drugs, examining potential benefits, risks, and the current lack of scientific evidence supporting this approach
Jorsal A, Kistorp C, Holmager P et al (2017) Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes ( LIVE )a multicentre, double-blind, randomised, placebo-controlled trial
Youll likely notice your appetite increases as medication effects wear off, and you may notice first menstrual cycle changes
This approach moves away from the traditional one-size-fits-all model and instead focuses on personalized, biomarker-guided targeted therapies and best practices tailored to an individual's unique biological profile (263)
They decrease gluconeogenesis: the process by which the liver releases stored glucose to elevate circulating blood sugar, often in response to stress